Skip to content
Clinical Trials – home

Fallopian tube cancer stage IV Diagnostics

2 / 2 trials open to patients8 countries

In short

Diagnosing fallopian tube cancer at stage IV is a complex process that requires careful examination and various tests, as the disease has already spread beyond the pelvis to distant organs like the lungs, liver, or spleen. Understanding what to expect during the diagnostic journey can help you and your family prepare for the steps ahead and feel more informed about the tests that doctors use to confirm this advanced stage of cancer.

Key points

  • Stage IV fallopian tube cancer means the disease has spread to distant organs like the lungs, liver, or spleen, or has caused fluid buildup around the lungs.
  • Symptoms such as persistent abdominal pain, bloating, and unusual vaginal discharge should not be ignored, especially if they last for weeks or worsen over time.
  • Diagnosis involves a combination of pelvic exams, imaging tests like ultrasound and CT scans, blood tests for tumor markers like CA-125, and biopsies taken during surgery.
  • The only definitive way to confirm cancer is through a biopsy, where tissue is examined under a microscope by a pathologist.
  • Fallopian tube cancer, ovarian cancer, and primary peritoneal cancer are staged and treated using the same system because they develop in similar tissue and behave alike.
  • Clinical trials may offer access to new treatments, but eligibility depends on confirming your diagnosis, stage, and sometimes specific genetic or molecular features of your cancer.
  • Women with BRCA gene mutations or a family history of breast or ovarian cancer should be especially vigilant and consider genetic testing.
  • Prognosis and survival depend on many factors, including how much cancer can be removed during surgery and how well it responds to treatment, with some patients benefiting greatly from newer therapies and clinical trials.

Introduction: Who Should Seek Diagnostics

If you are experiencing symptoms such as persistent abdominal pain, bloating, unusual vaginal discharge, or fluid buildup around your lungs, it's important to see your healthcare provider right away. These signs can be easy to ignore or confuse with other common conditions, but when they persist or worsen over time, they may indicate something more serious. Women who have a family history of ovarian, fallopian tube, or breast cancer, or those who carry genetic mutations in the BRCA genes — which are changes in certain genes that increase cancer risk — should be especially vigilant about seeking medical attention when new symptoms appear.

Stage IV fallopian tube cancer means that the disease has spread to distant parts of your body. This is divided into two substages. In stage IVa, cancer cells are found in the fluid surrounding your lungs, a condition called malignant pleural effusion, which happens when cancer causes fluid to build up between the lung and chest wall. In stage IVb, the cancer has traveled to the inside of organs like the liver or spleen, or to lymph nodes far from the abdomen, or even to other distant organs. Because the symptoms often don't appear until the cancer has already advanced and spread widely, many people are not diagnosed until they reach this later stage.

It's also worth noting that fallopian tube cancer, ovarian cancer, and primary peritoneal cancer — which starts in the lining of the abdomen — are all treated and staged using the same system because they develop in similar tissue and behave in similar ways. This means that the diagnostic process for fallopian tube cancer closely mirrors that used for ovarian and peritoneal cancers.

Diagnostic Methods for Identifying Fallopian Tube Cancer

When your healthcare provider suspects fallopian tube cancer, they will order a series of tests to confirm the diagnosis, determine the cancer's type, and understand how far it has spread. The journey to a confirmed diagnosis involves several steps, and each test provides a different piece of the puzzle.

Physical Examination

Your doctor will begin with a pelvic exam, during which they feel the ovaries, fallopian tubes, uterus, and nearby organs for any unusual lumps, masses, or areas of tenderness. This physical check helps identify whether there's anything abnormal that needs further investigation. Although a pelvic exam alone cannot diagnose cancer, it can raise suspicion and guide the next steps.

Imaging Tests

Imaging tests create pictures of the inside of your body and help doctors see where a tumor is located and whether it has spread. Several types of imaging may be used, depending on your symptoms and what your doctor needs to see more clearly.

Ultrasound is often one of the first imaging tests performed. It uses sound waves to create images of your pelvic organs. A special type called transvaginal ultrasound, where a small probe is placed inside the vagina, can provide detailed views of the ovaries and fallopian tubes.

If more detailed images are needed, your doctor may order a CT scan (computed tomography scan), which uses X-rays taken from different angles and combines them with a computer to create cross-sectional images of your body. CT scans are helpful in seeing whether cancer has spread to the abdomen, pelvis, or other distant areas.

An MRI (magnetic resonance imaging) uses powerful magnets and radio waves instead of radiation to produce detailed images of soft tissues. This can be especially useful for looking at the structure of tumors and nearby organs.

Blood Tests

Blood tests are an important part of the diagnostic process. One commonly used test measures the level of a protein called CA-125, which is a tumor marker — a substance that can be elevated in the blood when certain cancers are present. Many women with advanced fallopian tube or ovarian cancer have higher-than-normal CA-125 levels. However, CA-125 levels can also be elevated due to non-cancerous conditions such as endometriosis or pelvic infections, so this test is not used alone to diagnose cancer. Instead, it helps doctors decide whether further investigation is needed and can be used to monitor the disease over time.

Biopsy and Pathology

The only definitive way to know if you have cancer is through a biopsy, which involves taking a sample of tissue from the suspicious area and examining it under a microscope. In many cases, the biopsy is performed during surgery, when doctors remove tissue from the fallopian tubes, ovaries, or other affected areas.

The tissue sample is then sent to a laboratory, where a specialist called a pathologist examines the cells to determine whether they are cancerous, what type of cancer it is, and how abnormal the cells look, which is called the grade of the cancer. The pathologist's report is crucial because it provides detailed information that helps guide your treatment plan. You can ask for a copy of this report for your own records, and it typically takes between 5 and 10 days to receive the results.

Staging Through Surgery

For fallopian tube cancer, the most accurate way to determine the stage is through surgery. During the operation, the surgeon examines the pelvis and abdomen, takes samples of suspicious areas, and removes as much of the cancer as possible. This is called surgical staging. The surgeon may also check nearby lymph nodes and take fluid samples from the abdomen to see if cancer cells are present.

Staging helps doctors understand exactly how far the cancer has spread. Stage IV means the cancer has reached distant organs or caused fluid buildup in the lungs, or it has spread to the liver, spleen, or lymph nodes outside the abdomen. Knowing the precise stage helps your healthcare team plan the most appropriate treatment for you.

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies that test new treatments or combinations of treatments to see if they are safe and effective. For people with stage IV fallopian tube cancer, participating in a clinical trial may offer access to cutting-edge therapies that are not yet widely available. However, not everyone qualifies for every trial. Each study has specific criteria that participants must meet, and the diagnostic tests you undergo help determine whether you are eligible.

Confirming the Diagnosis and Stage

Most clinical trials require that your cancer diagnosis be confirmed through biopsy and that the stage of your disease be clearly documented. This means you will need to have completed the standard diagnostic tests, including imaging scans, blood tests, and surgical staging, so that researchers can be certain about the extent of your disease.

Genetic and Molecular Testing

Some clinical trials focus on patients whose cancers have specific genetic or molecular features. For example, trials may look for mutations in the BRCA1 or BRCA2 genes, or they may test tumor tissue for certain protein markers or changes in DNA. These tests help researchers match patients to treatments that are designed to target those specific features. If you are considering a clinical trial, your doctor may order additional genetic testing on your blood or tumor tissue to see if you qualify.

Assessing Overall Health

Clinical trials also evaluate your general health to ensure that you can safely participate. This might include blood tests to check your liver and kidney function, heart tests like an electrocardiogram (ECG) to measure your heart's electrical activity, and assessments of your overall physical condition. Researchers want to make sure that the trial treatment won't cause undue harm and that you are strong enough to handle the study's requirements.

Baseline Measurements

Before you begin a clinical trial, doctors take baseline measurements of your disease. This often includes detailed imaging scans to measure the size and location of tumors, as well as blood tests to establish starting levels of tumor markers like CA-125. These baseline results are compared to follow-up tests during and after the trial to see whether the treatment is working.

Participating in a clinical trial can be an opportunity to access innovative treatments that may help control the disease or improve quality of life. Your healthcare team can help you understand which trials you might qualify for and what diagnostic tests are needed to enroll.

Prognosis and Survival Rate

Prognosis

The prognosis for stage IV fallopian tube cancer depends on many factors, including where the cancer has spread, your overall health, and how well the cancer responds to treatment. Stage IV is considered advanced cancer, and while it is more challenging to treat than earlier stages, treatment can help control the disease, shrink tumors, and improve quality of life. Some patients respond very well to a combination of surgery and chemotherapy, and in certain cases, targeted therapies can offer additional benefits. The goal of treatment at this stage is often to manage symptoms, slow the progression of the disease, and help you maintain the best possible quality of life for as long as possible.

Survival rate

Survival rates for stage IV fallopian tube cancer vary and are closely related to how much cancer can be removed during surgery and how well the cancer responds to chemotherapy and other treatments. Because fallopian tube cancer is rare and is often grouped with ovarian and primary peritoneal cancers in research studies, exact survival statistics specific to fallopian tube cancer alone are limited. However, the overall approach and outcomes are similar to those for ovarian cancer. It's important to remember that survival statistics are based on large groups of people and cannot predict what will happen to any individual. Some people live much longer than average, especially with access to newer treatments and clinical trials. Your healthcare team is the best source of information about your personal prognosis and what you can expect based on your unique situation.

Did you know?

  1. For many years, fallopian tube cancer was thought to be extremely rare, but new research suggests that many cases of what was previously called ovarian cancer actually start in the fallopian tubes and then spread to the ovaries.
  2. The same staging system is used for ovarian cancer, fallopian tube cancer, and primary peritoneal cancer because they all develop from similar types of tissue and behave in very similar ways.
  3. Women with mutations in the BRCA1 or BRCA2 genes have a significantly higher risk of developing fallopian tube cancer, which is why genetic testing is an important part of assessing risk in families with a history of breast or ovarian cancer.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Fallopian tube cancer stage IV

Recruiting trials first

See all 2 trials →
Quick filters

2 clinical trials in this condition

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Nord Ostdeutsche Gesellschaft Fuer Gynaekologische Onkologie e.V.

Peritoneal sarcoma+5

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Arcagy Gineco
See all 2 trials →filters applied: condition = Fallopian tube cancer stage IV

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).